Annals of Surgical Oncology

, Volume 14, Issue 2, pp 597–604 | Cite as

Clinical Relevance of Pathological Grades of Malignant Peripheral Nerve Sheath Tumor: A Multi-Institution TMTS Study of 56 Cases in Northern Japan

  • Kyoji Okada
  • Tadashi Hasegawa
  • Takahiro Tajino
  • Tetsuo Hotta
  • Michiro Yanagisawa
  • Toshihisa Osanai
  • Jun Nishida
  • Kunihiko Seki
  • Eiji Itoi



Malignant peripheral nerve sheath tumor (MPNST) is a relatively rare soft tissue tumor, and its clinical relevance of pathological grades remains obscure.


Fifty-six cases of MPNST identified from the files of seven oncology centers of the Tohoku Musculoskeletal Tumor Society (TMTS) and National Cancer Center were analyzed for histologic grades, demographics, treatments, and prognostic factors. The average follow-up period was 41 months.


Twenty-two men and 34 women with a mean age of 45 years were involved. Forty-four (78.6%) of 56 tumors were in the lower extremity or trunk. Fifty tumors (89%) were classified as high grade, and the remaining six as low grade. Twenty-one (39.6%) of 53 patients who underwent tumor excision developed local recurrences. An axial site and inadequate surgical margin were defined as risk factors for local recurrence. The overall survival rates of the 56 patients were 55.1% at 3 years and 43.3% at 5 years. Univariate analysis of the 56 patients revealed large-sized tumors, metastasis at presentation, and histologically high grade were significantly associated with poor prognosis. Multivariate analysis revealed a large tumor and metastasis at presentation to be independent prognostic factors.


The current study involving 56 patients with MPNST showed the aggressive clinical behavior of the tumor. Large-sized tumors, metastasis at presentation, and high histological grade were related to poor prognosis on univariate analysis, but independency of histological grade was still obscure. In the treatment for a large and high-grade MPNST, an alternative strategy should be further considered.


Malignant peripheral nerve sheath tumor Sarcoma Diagnosis Histology 


  1. 1.
    Lewis JJ, Brennan MR. Soft tissue sarcomas. Curr Probl Surg 1996; 33:817–72PubMedCrossRefGoogle Scholar
  2. 2.
    Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity: a study of 43 cases. Cancer 1990; 66:1253–65PubMedCrossRefGoogle Scholar
  3. 3.
    Vauthey J-N, Woodruff JM, Brennan MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol 1995; 2:126–31PubMedCrossRefGoogle Scholar
  4. 4.
    Kim DH, Murovic JA, Tiel RL, Moes G, Kling DG. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Heath Science Center. J Neurosurg 2005; 102:246–55PubMedCrossRefGoogle Scholar
  5. 5.
    Scheithauer BW, Woodruff JM, Erlandson RA. (1999) Primary malignant tumors of peripheral nerve. In: Atlas of Tumor Pathology: Tumors of the Peripheral Nervous System (3rd series, fascicle 24). Washington, DC: Armed Forces Institute of Pathology. pp 303–72Google Scholar
  6. 6.
    Hirose T, Scheithauer BW, Sano T. Perineural malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. Am J Surg Pathol 1998; 22:1368–78PubMedCrossRefGoogle Scholar
  7. 7.
    Yamaguchi U, Hasegawa T, Hirose T, et al. Low grade malignant peripheral nerve sheath tumour: varied cytological and histological patterns. J Clin Pathol 2003; 56:826–30PubMedCrossRefGoogle Scholar
  8. 8.
    Enneking WF, Maale GE. The effect of inadvertent tumor contamination of wounds during the surgical resection of musculoskeletal neoplasms. Cancer 1988; 62:1251–6PubMedCrossRefGoogle Scholar
  9. 9.
    Tsuneyoshi M, Enjoji M. Primary malignant peripheral nerve tumors (malignant schwannomas): a clinicopathologic and electron microscopic study. Acta Pathol Jpn 1979; 29:363–75PubMedGoogle Scholar
  10. 10.
    Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persint JA. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 28 cases. Cancer 1993; 71:1247–57PubMedCrossRefGoogle Scholar
  11. 11.
    Sordillo PP, Helson L, Hajdu SI, Magill GB, Kosloff C, Golbey RB, Beattie EJ. Malignant schwannoma—clinical characteristics, survival, and response to therapy. Cancer 1981; 47:2503–9PubMedCrossRefGoogle Scholar
  12. 12.
    Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 1998; 42:351–60PubMedGoogle Scholar
  13. 13.
    Trojanowski JQ, Kleinman GM, Proppe KH. Malignant tumors of nerve sheath origin. Cancer 1980; 46:1202–12PubMedCrossRefGoogle Scholar
  14. 14.
    Leroy K, Dumas V, Martin-Garcia N, et al. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol 2001; 137:908–13PubMedGoogle Scholar
  15. 15.
    Weiss SA, Goldblum JR. (2001) Malignant tumors of the peripheral nerves. In: Enzinger, Weiss’s Soft Tissue Tumors. 4th ed. St Louis MO: CV Mosby. pp 1209–63Google Scholar
  16. 16.
    Ariel IM. Tumours of the peripheral nervous system. Semin Surg Oncol 1988; 4:7–12PubMedCrossRefGoogle Scholar
  17. 17.
    Raney B, Schnaufer L, Ziegler M, Chatten J, Littman P, Jarrett P. Treatment of children with neurogenic sarcoma: experience at the Children’s hospital of Philadelphia, 1958–1984. Cancer 1987; 59:1–5PubMedCrossRefGoogle Scholar
  18. 18.
    Kamada T, Tsuji H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002; 20:4466–71PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2006

Authors and Affiliations

  • Kyoji Okada
    • 1
    • 2
  • Tadashi Hasegawa
    • 3
  • Takahiro Tajino
    • 1
    • 4
  • Tetsuo Hotta
    • 1
    • 5
  • Michiro Yanagisawa
    • 1
    • 6
  • Toshihisa Osanai
    • 1
    • 7
  • Jun Nishida
    • 1
    • 8
  • Kunihiko Seki
    • 9
  • Eiji Itoi
    • 1
    • 2
  1. 1.Tohoku Musculoskeletal Tumor SocietyYamagataJapan
  2. 2.Department of Orthopedic SurgeryAkita University School of MedicineAkitaJapan
  3. 3.Department of Surgical PathologySapporo Medical UniversitySapporoJapan
  4. 4.Department of Orthopedic SurgeryFukushima Medical UniversityFukushimaJapan
  5. 5.Department of Orthopedic SurgeryNiigata University, Graduate School of Medicine and Dental ScienceNiigataJapan
  6. 6.Department of Orthopedic SurgeryNational Hirosaki HospitalHirosakiJapan
  7. 7.Department of Orthopedic SurgeryYamagata University School of MedicineYamagataJapan
  8. 8.Department of Orthopedic SurgeryIwate Medical SchoolMoriokaJapan
  9. 9.Pathology DivisionNational Cancer CenterTokyoJapan

Personalised recommendations